Overall Survival, Costs, and Healthcare Resource Use by Line of Therapy in Medicare Patients With Newly Diagnosed Metastatic Urothelial Carcinoma
Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1591424
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 25, 2019
Authors
Publisher
Informa UK Limited